WebNov 18, 2024 · BOSTON, November 18, 2024 -- ( BUSINESS WIRE )--Gelesis Holdings Inc. (NYSE: GLS) ("Gelesis" or the "Company") today noted that on November 16, 2024, the Company received a notification... WebMar 10, 2024 · Gelesis Named One of the World’s Most Innovative Companies for 2024 by Fast Company. Boston (March 10, 2024) – Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, has been named to Fast Company’s prestigious annual list …
NYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) an…
Webwww.gelesis.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Stock Exchange NYS Primary Office 501 Boylston Street Suite 6102 Boston, MA 02116 United States +1 (617) 000-0000 Gelesis Timeline 2024 2024 2024 2024 WebMay 12, 2024 · Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis”) is a consumer-centered biotherapeutics company and the maker of Plenity®, which is inspired by nature and FDA cleared to aid in weight... taic monomer
Capstar Special Purpose Acquisition : Gelesis, a Consumer …
WebIn January 2024, Gelesis appointed Inogen Co-Founder and former CFO, Ali Bauerlein, to its board of directors and Audit Committee. Ms. Bauerlein brings success in scaling to over $300 million revenue in a direct-to … WebJul 20, 2024 · Jul 20, 2024 For the second time in six years, weight loss-focused company Gelesis Inc. has eschewed the IPO route. But this time, it's still planning to go public — just via a merger with a... WebJun 2, 2024 · CE Mark enables Gelesis to market Plenity™ throughout the European Economic Area. BOSTON, June 2, 2024 - Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, announced today that it has received approval to market … taic my horsis